Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$232.24 - $267.23 $1,161 - $1,336
-5 Reduced 0.51%
970 $236,000
Q2 2023

Aug 03, 2023

SELL
$238.39 - $265.32 $16,687 - $18,572
-70 Reduced 6.7%
975 $257,000
Q4 2021

Jan 31, 2022

BUY
$230.08 - $250.94 $9,203 - $10,037
40 Added 3.98%
1,045 $263,000
Q2 2021

Jul 29, 2021

SELL
$232.65 - $254.58 $16,750 - $18,329
-72 Reduced 6.69%
1,005 $244,000
Q1 2021

Apr 22, 2021

BUY
$232.09 - $256.88 $3,249 - $3,596
14 Added 1.32%
1,077 $262,000
Q4 2020

Jan 29, 2021

SELL
$221.92 - $245.94 $2.19 Million - $2.42 Million
-9,855 Reduced 90.26%
1,063 $266,000
Q3 2020

Oct 26, 2020

SELL
$215.77 - $276.76 $4,962 - $6,365
-23 Reduced 0.21%
10,918 $2.54 Million
Q2 2020

Jul 24, 2020

BUY
$219.9 - $263.41 $14,293 - $17,121
65 Added 0.6%
10,941 $2.62 Million
Q1 2020

Apr 16, 2020

BUY
$195.69 - $279.01 $143,049 - $203,956
731 Added 7.21%
10,876 $2.5 Million
Q4 2019

Jan 23, 2020

BUY
$236.45 - $266.82 $146,599 - $165,428
620 Added 6.51%
10,145 $2.76 Million
Q3 2019

Oct 18, 2019

SELL
$230.58 - $256.08 $27,669 - $30,729
-120 Reduced 1.24%
9,525 $2.41 Million
Q2 2019

Aug 01, 2019

BUY
$217.4 - $246.08 $21,740 - $24,608
100 Added 1.05%
9,645 $2.43 Million
Q1 2019

Apr 26, 2019

BUY
$206.05 - $248.17 $426,523 - $513,711
2,070 Added 27.69%
9,545 $2.38 Million
Q4 2018

Jan 25, 2019

BUY
$204.73 - $257.93 $571,196 - $719,624
2,790 Added 59.55%
7,475 $1.68 Million
Q2 2018

Jul 20, 2018

BUY
$208.1 - $233.85 $250,760 - $281,789
1,205 Added 34.63%
4,685 $1.12 Million
Q1 2018

Apr 30, 2018

BUY
$205.46 - $240.27 $715,000 - $836,139
3,480 New
3,480 $754,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Spc Financial, Inc. Portfolio

Follow Spc Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spc Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spc Financial, Inc. with notifications on news.